Skip to main content
. 2024 Dec 23;30:269. doi: 10.1186/s10020-024-01047-8

Fig. 2.

Fig. 2

ADAM19 expression in skin tissues of SSc patients and HOCl-induced experimental models of fibrosis. (a) Expression levels of the ADAM19 protein in skin tissues of HC, SSc patients, PBS, and HOCl induced fibrosis mouse model. (b) Expression levels of the ADAM19 and fibrosis-related genes (ACTA2, COL1A1, COL1A2, and FN1) mRNA in skin tissues of PBS and HOCl-induced fibrosis mouse model. (c) Expression levels of the ADAM19 and fibrosis-related genes (ACTA2, COL1A1, COL1A2, and FN1) mRNA in isolated primary dermal fibroblasts of HC and SSc patients. (d) Expression levels of the ADAM19 and ACTA2 protein in isolated primary dermal fibroblasts of HC and SSc patients. SSc, systemic sclerosis; HC, healthy controls; HOCl, hypochlorous acid; PBS, phosphate buffer saline. Data are represented as mean ± SEM. *, P < 0.05, **, P < 0.01. ****, P < 0.0001